Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $17.17 billion. The enterprise value is $16.81 billion.
| Market Cap | 17.17B |
| Enterprise Value | 16.81B |
Important Dates
The next confirmed earnings date is Wednesday, October 21, 2026, after market close.
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 27.91 million shares outstanding. The number of shares has decreased by -7.24% in one year.
| Current Share Class | 27.91M |
| Shares Outstanding | 27.91M |
| Shares Change (YoY) | -7.24% |
| Shares Change (QoQ) | -1.41% |
| Owned by Insiders (%) | 18.93% |
| Owned by Institutions (%) | 89.21% |
| Float | 22.61M |
Valuation Ratios
The trailing PE ratio is 36.06 and the forward PE ratio is 33.60. MEDP's PEG ratio is 2.65.
| PE Ratio | 36.06 |
| Forward PE | 33.60 |
| PS Ratio | 6.21 |
| Forward PS | 5.94 |
| PB Ratio | 39.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.44 |
| P/OCF Ratio | 22.95 |
| PEG Ratio | 2.65 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.68, with an EV/FCF ratio of 23.94.
| EV / Earnings | 34.42 |
| EV / Sales | 6.08 |
| EV / EBITDA | 27.68 |
| EV / EBIT | 28.99 |
| EV / FCF | 23.94 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.33.
| Current Ratio | 0.73 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 162.15% and return on invested capital (ROIC) is 573.33%.
| Return on Equity (ROE) | 162.15% |
| Return on Assets (ROA) | 20.10% |
| Return on Invested Capital (ROIC) | 573.33% |
| Return on Capital Employed (ROCE) | 93.83% |
| Weighted Average Cost of Capital (WACC) | 10.48% |
| Revenue Per Employee | $448,756 |
| Profits Per Employee | $79,274 |
| Employee Count | 6,200 |
| Asset Turnover | 1.53 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $107.42 million in taxes.
| Income Tax | 107.42M |
| Effective Tax Rate | 17.94% |
Stock Price Statistics
The stock price has increased by +24.44% in the last 52 weeks. The beta is 1.15, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +24.44% |
| 50-Day Moving Average | 593.57 |
| 200-Day Moving Average | 522.45 |
| Relative Strength Index (RSI) | 58.11 |
| Average Volume (20 Days) | 236,231 |
Short Selling Information
The latest short interest is 1.69 million, so 6.04% of the outstanding shares have been sold short.
| Short Interest | 1.69M |
| Short Previous Month | 1.67M |
| Short % of Shares Out | 6.04% |
| Short % of Float | 7.46% |
| Short Ratio (days to cover) | 8.45 |
Income Statement
In the last 12 months, MEDP had revenue of $2.78 billion and earned $491.50 million in profits. Earnings per share was $17.06.
| Revenue | 2.78B |
| Gross Profit | 2.01B |
| Operating Income | 583.40M |
| Pretax Income | 598.92M |
| Net Income | 491.50M |
| EBITDA | 611.20M |
| EBIT | 583.40M |
| Earnings Per Share (EPS) | $17.06 |
Balance Sheet
The company has $502.69 million in cash and $144.11 million in debt, with a net cash position of $358.58 million or $12.85 per share.
| Cash & Cash Equivalents | 502.69M |
| Total Debt | 144.11M |
| Net Cash | 358.58M |
| Net Cash Per Share | $12.85 |
| Equity (Book Value) | 433.86M |
| Book Value Per Share | 15.54 |
| Working Capital | -385.14M |
Cash Flow
In the last 12 months, operating cash flow was $752.66 million and capital expenditures -$45.97 million, giving a free cash flow of $706.69 million.
| Operating Cash Flow | 752.66M |
| Capital Expenditures | -45.97M |
| Depreciation & Amortization | 27.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 706.69M |
| FCF Per Share | $25.32 |
Margins
Gross margin is 72.35%, with operating and profit margins of 20.97% and 17.67%.
| Gross Margin | 72.35% |
| Operating Margin | 20.97% |
| Pretax Margin | 21.53% |
| Profit Margin | 17.67% |
| EBITDA Margin | 21.97% |
| EBIT Margin | 20.97% |
| FCF Margin | 25.40% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.24% |
| Shareholder Yield | 7.24% |
| Earnings Yield | 2.85% |
| FCF Yield | 4.09% |
Analyst Forecast
The average price target for MEDP is $581.83, which is -5.40% lower than the current price. The consensus rating is "Hold".
| Price Target | $581.83 |
| Price Target Difference | -5.40% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 9.49% |
| EPS Growth Forecast (3Y) | 12.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 6.89 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.89 |
| Piotroski F-Score | 7 |